Abpro Bio Statistics

Total Valuation

Abpro Bio has a market cap or net worth of KRW 83.41 billion. The enterprise value is 87.33 billion.

Market Cap	83.41B
Enterprise Value	87.33B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Abpro Bio has 284.69 million shares outstanding. The number of shares has increased by 1.31% in one year.

Current Share Class	284.69M
Shares Outstanding	284.69M
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.21%
Owned by Institutions (%)	0.43%
Float	264.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.42
PB Ratio	0.80
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.81
EV / Sales	2.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.26

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.21.

Current Ratio	2.16
Quick Ratio	1.37
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	-1.08
Interest Coverage	-4.30

Financial Efficiency

Return on equity (ROE) is -15.98% and return on invested capital (ROIC) is -3.64%.

Return on Equity (ROE)	-15.98%
Return on Assets (ROA)	-3.33%
Return on Invested Capital (ROIC)	-3.64%
Return on Capital Employed (ROCE)	-6.63%
Revenue Per Employee	765.10M
Profits Per Employee	-403.74M
Employee Count	45
Asset Turnover	0.24
Inventory Turnover	2.22

Taxes

Income Tax	-434.23M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.49% in the last 52 weeks. The beta is 2.03, so Abpro Bio's price volatility has been higher than the market average.

Beta (5Y)	2.03
52-Week Price Change	-38.49%
50-Day Moving Average	301.60
200-Day Moving Average	393.39
Relative Strength Index (RSI)	38.88
Average Volume (20 Days)	797,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abpro Bio had revenue of KRW 34.43 billion and -18.17 billion in losses. Loss per share was -67.58.

Revenue	34.43B
Gross Profit	1.07B
Operating Income	-7.76B
Pretax Income	-18.60B
Net Income	-18.17B
EBITDA	-6.26B
EBIT	-7.76B
Loss Per Share	-67.58

Full Income Statement

Balance Sheet

The company has 18.25 billion in cash and 22.17 billion in debt, giving a net cash position of -3.92 billion or -13.76 per share.

Cash & Cash Equivalents	18.25B
Total Debt	22.17B
Net Cash	-3.92B
Net Cash Per Share	-13.76
Equity (Book Value)	104.86B
Book Value Per Share	368.34
Working Capital	24.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.08 billion and capital expenditures -12.40 billion, giving a free cash flow of -20.48 billion.

Operating Cash Flow	-8.08B
Capital Expenditures	-12.40B
Free Cash Flow	-20.48B
FCF Per Share	-71.94

Full Cash Flow Statement

Margins

Gross margin is 3.09%, with operating and profit margins of -22.53% and -52.77%.

Gross Margin	3.09%
Operating Margin	-22.53%
Pretax Margin	-54.03%
Profit Margin	-52.77%
EBITDA Margin	-18.17%
EBIT Margin	-22.53%
FCF Margin	n/a

Dividends & Yields

Abpro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	n/a
Earnings Yield	-21.78%
FCF Yield	-24.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 21, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Aug 21, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

Abpro Bio has an Altman Z-Score of 1.28 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	4